Archives
-
Gap26 and the Next Era of Cx43 Mechanobiology
2026-10-05
A translational perspective on how Gap26 can help interrogate connexin 43-dependent calcium and ATP signaling in advanced three-dimensional mechanobiology models, anchored by recent osteocyte-network research.
-
ARCA-Capped mRNA Synthesis in Vaccine Research
2026-10-05
This overview places the HyperScribe All in One mRNA Synthesis Kit in the broader context of capped and polyadenylated RNA research, while examining the 2026 Cell Reports Medicine study of a spleen-targeted neoantigen mRNA vaccine in hepatocellular carcinoma. The findings are promising but remain preclinical and should not be interpreted as evidence that the commercial kit itself was used in, or validated by, that vaccine study.
-
3D Proteomics and Carboplatin Response in HGSOC
2026-10-04
Maillard and colleagues compare whole-cell proteomes from four high-grade serous ovarian carcinoma models grown in 2D and 3D, showing that culture dimensionality reshapes metabolic, membrane-associated, and drug-response biology. The findings support more careful interpretation of Carboplatin response in spheroid systems while highlighting why proteomic associations should not be treated as validated resistance mechanisms.
-
GSK2606414 in PERK and ER Stress Research
2026-10-03
GSK2606414 is a widely used pharmacological tool for examining PERK-dependent signaling, but evidence from supplier data and disease models should be separated carefully. Recent zebrafish and cell research links TMAO exposure with PERK pathway activation and liver pathology, while the available evidence does not by itself establish that GSK2606414 reverses those effects or proves PERK is solely responsible.
-
Capsazepine TRPV1 Research Workflows
2026-10-01
Capsazepine supports controlled dissection of TRPV1-mediated calcium signaling, capsaicin-evoked nociception, and related TRPM8 effects. This workflow also shows how to extend channel pharmacology into exploratory apoptosis sensitization studies while managing concentration-dependent off-target activity.
-
CB-5083 p97 Inhibitor Workflows
2026-10-01
CB-5083 provides a practical way to perturb p97-dependent protein quality control and connect ubiquitin accumulation with unfolded protein response, apoptosis, and tumor-model endpoints. This workflow also shows how ER lipid-homeostasis assays can sharpen interpretation without mistaking a mechanistic bridge for direct evidence.
-
CBD and Orofacial Inflammatory Pain Mechanisms
2026-09-30
A 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce both inflammatory nociception and pain-related affective deficits in mice through distinct peripheral and central endocannabinoid mechanisms. Its combination of behavioral profiling, molecular assays, metabolite analysis, and fiber photometry provides a useful framework for neuroscience research on pain–emotion interactions.
-
NADPH Oxidase ROS and Arterial Contraction
2026-09-30
The reference study identifies L-type voltage-gated Ca2+ channels as the principal downstream mediators of NADPH oxidase-derived ROS contraction in early postnatal rat saphenous arteries. Its inhibitor-occlusion design separates this mechanism from Rho-kinase, PKC, and Src-kinase pathways, providing a useful framework for interpreting redox-dependent vascular signaling.
-
Dual Luciferase Assay System: Reliable Workflows
2026-09-29
Learn how the Dual Luciferase Assay System, SKU K1136, addresses normalization, compatibility, workflow, interpretation, and vendor-selection challenges in reporter experiments. This scenario-driven guide connects practical mammalian-cell assay design with evidence-based gene expression regulation studies.
-
Heparin Sodium at the Nanovesicle–Cell Interface
2026-09-29
Heparin sodium is more than a glycosaminoglycan anticoagulant: it can become a critical experimental variable when nanovesicle uptake depends on heparan sulfate proteoglycans. This article connects coagulation assays with cell-interface biology while defining practical controls for reproducible research.
-
EGFP mRNA m1Ψ: Applied Assay Workflows
2026-09-28
Use EGFP mRNA m1Ψ to distinguish delivery, translation, cell health, and formulation effects instead of treating fluorescence as a single endpoint. This practical workflow covers dose finding, time-course analysis, storage studies, troubleshooting, and translation of LNP formulation findings into reporter assays.
-
Naringin Targets Hepatocyte VEGFC in NASH Fibrosis
2026-09-28
A high-fat-diet mouse study identifies hepatocyte-derived VEGFC as a signal linking liver injury to macrophage recruitment and phenotype, and finds that naringin suppresses this pathway alongside hepatic inflammation and fibrosis. Human data, hepatocyte-specific Vegfc deletion, and pharmacological VEGFR-3 inhibition provide complementary evidence, while leaving clinical efficacy and pathway specificity to be tested.
-
Regorafenib: Practical Workflows for Cancer Research
2026-09-27
Use Regorafenib (BAY 73-4506) to connect multikinase inhibition with measurable changes in angiogenesis, tumor-cell behavior, and melanoma biology. This guide translates product data and a recent RRM2 study into assay choices, practical starting conditions, and troubleshooting steps.
-
Oleic Acid (C18:1(9Z)) in Lipid Research
2026-09-26
Oleic Acid (C18:1(9Z)) is a monounsaturated fatty acid used to investigate lipid metabolism, membrane biology, and signaling. A recent hepatic injury study used oleic acid with palmitic acid to create a lipid-loaded hepatocyte model, but its therapeutic findings concern Rehmanniae Radix Praeparata rather than oleic acid treatment.
-
Carvedilol in Cell Assays: Practical Design Guide
2026-09-25
A scenario-driven guide to using Carvedilol (SKU B1332) in viability, proliferation, and oxidative-stress workflows. It connects concentration selection, solvent handling, assay interpretation, and hematopoietic research cautions to product data and published evidence.